RT Journal Article
SR Electronic
T1 Public attitudes towards COVID-19 vaccination in children: A qualitative study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.28.21261252
DO 10.1101/2021.07.28.21261252
A1 Williams, Simon N
YR 2021
UL http://medrxiv.org/content/early/2021/07/31/2021.07.28.21261252.abstract
AB Background COVID-19 vaccinations in children remains controversial. In the UK, as of August 2021, they have not been approved, except in a few limited circumstances. To date, little qualitative research exists to explain the reasons and nuances behind public attitudes on this issue.Methods Qualitative group and one-to-one online interviews were conducted with a diverse sample of 24 adults to explore their views on the issue of COVID-19 vaccination in children.Results COVID-19 vaccination in children was framed as a complex problem (a “minefield”). Six themes emerged to explain participants views: (1) Uncertainty over whether children can catch, transmit or be severely harmed by COVID-19; (2) Lower risk tolerance for unknown longer-term effects of the vaccine in children; (3) Association of the vaccine program with government’s handling of the pandemic; (4) Local social norms as a driver of hesitancy; (5) Vaccinating children as a way to protect vulnerable adults; (6) Children’s vaccination as parental choice.Conclusions Public attitudes to COVID-19 vaccination in children are likely to be met with more hesitancy compared to adult vaccinations. Public health communications will need to combat this hesitancy if vaccine uptake for children is to be pursued as a public health policy.Competing Interest StatementThe author is currently funded for a separate project collaborating with Public Health Wales. This or any other funding body did not play any role in the present study.Funding StatementThis research was supported by the Manchester Centre for Health Psychology based at the University of Manchester (GBP2000) and Swansea University's'Greatest Need Fund' (GBP3000).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was received by Swansea University's School of Management Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesEthical restrictions related to participant confidentiality prohibit the authors from making the data set publicly available. During the consent process, participants were explicitly guaranteed that the data would only be seen my members of the study team. For any discussions about the data set please contact the corresponding author, Simon Williams (s.n.williams@swansea.ac.uk).